Handelsbanken Fonder’s Praxis Precision Medicines PRAX Stock Holding History

Handelsbanken Fonder’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.29M	Buy	+9,840	New	+$3.11M	0.01%	628

Other funds holding PRAX

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Handelsbanken Fonder's PRAX Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 9,840 shares worth $3.29M. The stake represents 0.01% of the portfolio and ranks #628 among its holdings.

45 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Handelsbanken Fonder held 9,840 shares of Praxis Precision Medicines worth $3.29M as of Q2 2026.
Praxis Precision Medicines was a new Handelsbanken Fonder position in Q2 2026.
Praxis Precision Medicines made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #628 holding.
45 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.